Febuxostat
- 1 lab in 1 country
- Funders: National Science and Technology Council and 2 more
- Humans1
Associations
1Frailty
upin humans1HR 1.22
1 study
Frailty
upin humans1HR 1.22
Febuxostat raises the risk of frailty in humans (HR 1.22, 95% CI 1.01-1.48).
Humansin nephrology patients versus non-usersmedian follow-up of 3.0 yearsn = 19,389
International journal of medical sciences4 Aug 2026
Latest
1 in 12 monthsInternational Journal of Medical Sciences
Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients
Cohort study of 19,389 peoplePopulations